Related content

Levofloxacin

By Norrby S.R.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 109-119

Informa Healthcare

Access to resources Recommend Favorite

Analysis and standardization of the new domestic antiarrhythmic drug bradizol

By Barteneva E.   Stepanenko O.   Avdyunina N.   Bol’shakova R.   Klimova N.   Ustinova M.   Pyatin B.  

Pharmaceutical Chemistry Journal, Vol. 38, Iss. 12, 2004-12 ,pp. : 703-706

Springer Publishing Company

Access to resources Recommend Favorite

Analysis and standardization of the new anxiolytic drug afobazole

By Milkina S.   Stepanenko O.   Grushevskaya L.   Avdyunina N.   Pyatin B.   Bagirova V.   Nechaeva E.  

Pharmaceutical Chemistry Journal, Vol. 40, Iss. 7, 2006-07 ,pp. : 405-406

Springer Publishing Company

Access to resources Recommend Favorite

Analysis and Standardization of the New Psychotropic and Immunotropic Drug Ladasten

By Karavanova D. E.   Pyatin B. M.   Klimova N. V.   Avdyunina N. I.   Stepanenko O. B.   Tsvetkova E. A.   Shamenkova N. V.   Prokof'eva V. I.  

Pharmaceutical Chemistry Journal, Vol. 37, Iss. 10, 2003-10 ,pp. : 543-546

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of the Addressing Substance-Related Offending (ASRO) Program for Substance-Using Offenders in the Community: A Reconviction Analysis

By Palmer Emma   Hatcher Ruth   McGuire James   Bilby Charlotte   Ayres Tammy   Hollin Clive  

Substance Use & Misuse, Vol. 46, Iss. 8, 2011-05 ,pp. : 1072-1080

Informa Healthcare

Access to resources Recommend Favorite